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Head and neck cancer
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In the last years, there were big steps in the treatment of head and neck cancer (HNC), but local relapse rates are still very high.
In our hospital, we started a research project (2012–2014) focused on quantifying tumour response of HNC patients (#50) by serial
PET/CT and MRI (Apparent Diffusion Coefﬁcient – ADC). The aim of this video is to present our methodology, our preliminary
results (#5), and illustrate patient’s experiences. For this study we select “oropharynx T3 and T4” patients. The standard dose to
the PTV is 66Gy by IMRT (S&S). The imaging protocol will be as follows; pre-treatment: MRI study (diffusion-weighted MR) and
PET/CT study (18F-FDG). First control (10–20Gy):MRI diffusion study. Second control (20–50Gy):MRI diffusion study. Threemonths
after the treatment: PET/CT and MRI diffusion studies. For all the studies the patient is positioned using the RT immobilisation
devices to ease image registration. For each patient and each set of images the ADC values, SUV, dose and HU per voxel were
recorded of each volume. An interview to patients was performed and they can explain freely their experiences. The average
initial ADC value obtained for tumour and node volumes was 1.29×10−3 mm2/s. The relationship of ADC vs dose is always a
rising function. Controls performed three months after treatment shows no local relapses in the only ended patient. ADC can be
used not only for treatment assessment, but also for quantiﬁcation of tumour response voxel by voxel. Even more, the joint use
of MRI and PET/CT can be useful for delimiting the hypoxic areas, due to glucose consumption enhancement by Pasteur effect in
hypoxic cells. Although most participating patients complain of lost time, all of them will participate again. Supported by ISCIII
Grant PI11/02035.
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